Average life expectancy in Saudi Arabia rises to 79.9 years | Health achievement
Coinciding with World Health Day, the Health Transformation Program announced exceptional achievements reflecting the development of the healthcare system in the Kingdom of Saudi Arabia. Foremost among these achievements is the remarkable increase in life expectancy in Saudi Arabia, which jumped from 74 years in 2016 to 79.9 years by the end of 2025. This impressive progress puts the Kingdom one step closer to achieving the strategic goal of Saudi Vision 2030, which is to reach an average life expectancy of 80 years, reflecting the wise leadership's commitment to enhancing the quality of life and health of citizens and residents.
The historical context of the development of medical care and the rise in life expectancy in Saudi Arabia
This achievement was not a sudden occurrence, but rather the fruit of meticulous strategic planning that began with the launch of Saudi Vision 2030. Historically, the Kingdom's healthcare sector has undergone radical transformations; after focusing on providing primary care, the emphasis has shifted towards preventative care and advanced medical innovation. This announcement coincides with World Health Day, which the World Health Organization has celebrated annually on April 7 since its founding in 1948 to highlight priority health issues. This year's theme underscores the importance of integrated efforts and harnessing science and innovation to build a sustainable and healthy future for all, a path that the Kingdom strongly embraces in its development plans.
A qualitative leap in clinical trials and scientific research
This significant leap in health indicators is attributed to the rapid expansion and increased focus on clinical trials. These trials recorded remarkable growth of 51.4% between 2023 and 2025. Furthermore, the healthcare system successfully reduced the average initiation time for these trials by 48%, directly contributing to accelerating access to innovative treatment solutions and maximizing the benefits of scientific research outputs. In the research environment, the number of companies sponsoring clinical trials increased by 36%, while the number of trial sites reached 13. These figures underscore the Kingdom's ability to attract high-quality investments and strengthen its scientific partnerships both domestically and internationally.
Strategic dimensions and overall impact of health transformation
The rise in health indicators has profound implications and far-reaching effects. Locally, this progress translates into a tangible improvement in individuals' quality of life and increased economic productivity resulting from enjoying better health for longer periods. Regionally, this development solidifies the Kingdom's position as a leading center for medical innovation in the Middle East, making it a preferred destination for advanced medical research. Internationally, this achievement enhances the credibility of the Saudi healthcare sector in the eyes of global organizations and foreign investors, opening new avenues for international collaboration in the fields of biotechnology and pharmaceuticals.
A promising future towards global health leadership
In this context, Dr. Khalid Al-Shaibani, CEO of the Health Sector Transformation Program, explained that the rapid growth in the clinical trials sector clearly reflects the Kingdom's transformation into a regional hub for health innovation. Dr. Al-Shaibani emphasized that continuous investment in science and medical research is now translating into tangible results that positively impact human health. These integrated efforts are not limited to treating diseases but extend to preventing them, ensuring the building of a vibrant society whose members enjoy health and well-being, perfectly aligned with the ambitious aspirations of the Kingdom's Vision 2030 to build a sustainable, world-class healthcare sector.
